ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 4,501 | 5,596 | 6,659 |
| Gross Profit | 2,088 | 2,325 | 707 |
| Operating Income | -505 | -339 | 297 |
| Net Income | -1,165 | -20 | 463 |
| EBITDA | 650 | 621 | 1,429 |
| EPS Diluted | -28.55 | -0.48 | 11.35 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 157 | 43 | 226 |
| Total Current Assets | 5,499 | 3,976 | 5,010 |
| Total Assets | 12,373 | 11,106 | 12,252 |
| Total Current Liabilities | 1,421 | 2,408 | 3,719 |
| Total Liabilities | 5,843 | 4,632 | 5,366 |
| Total Equity | 6,529 | 6,474 | 6,886 |
| Total Debt | 4,527 | 2,680 | 3,313 |
| Net Debt | 4,370 | 2,636 | 3,087 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | 236 | 925 | 183 |
| Capital Expenditure | -6 | -144 | -849 |
| Free Cash Flow | 230 | 781 | -666 |
| Stock-Based Comp | 0 | 0 | 0 |
| Net Change in Cash | -742 | -114 | 183 |